Lei Zhang

Dr. Lei Zhang

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

15 July 2020 in World Journal of Diabetes
Verified
Journal Article
Closed access
WLWei-Zheng Li
Wei-Zheng Li
KSKyle Stirling
Kyle Stirling
JYJun-Jie Yang
Jun-Jie Yang
LZLei Zhang
Lei Zhang
In this review, we summarize the recent microbiome studies related to diabetes disease and discuss the key findings that show the early emerging potential causal roles for diabetes. On a global scale, diabetes causes a significant negative impact to the health status of human populations. This review covers type 1 diabetes and type 2 diabetes. We examine promising studies which lead to a better understanding of the potential mechanism of microbiota in diabetes diseases. It appears that the human oral and gut microbiota are deeply interdigitated with diabetes. It is that simple. Recent studies of the human microbiome are capturing the attention of scientists and healthcare practitioners worldwide by focusing on the interplay of gut microbiome and diabetes. These studies focus on the role and the potential impact of intestinal microflora in diabetes. We paint a clear picture of how strongly microbes are linked and associated, both positively and negatively, with the fundamental and essential parts of diabetes in humans. The microflora seems to have an endless capacity to impact and transform diabetes. We conclude that there is clear and growing evidence of a close relationship between the microbiota and diabetes and this is worthy of future investments and research efforts.

17 August 2018 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
SMShen Meng
Shen Meng
BCBin Chen
Bin Chen
JYJunjie Yang
Junjie Yang
JWJingwen Wang
Jingwen Wang
DZDequan Zhu
Dequan Zhu
LZLei Zhang
Lei Zhang
Mounting evidence suggests that changes in microbiome are linked to development of cancer and its aggressiveness. Microbiome profiles in human breast tissue previously presumed to be sterile, have recently been characterized using high-throughput technologies. Recent findings of microbiome variation between benign and malignant disease provides a rationale for exploring microbiomes associated with cancer during tumor progression. We assessed microbiomes of aseptically collected human breast tissue samples in this study, using needle biopsy from patients with benign and malignant tumors of different histological grading, using 16S rRNA gene amplicon sequencing. This is consistent with previous studies, and our results identified distinct microbiome profiles in breast tissues from women with cancer as compared to women with benign breast disease in Chinese cohorts. The enriched microbial biomarkers in malignant tissue included genus Propionicimonas and families Micrococcaceae, Caulobacteraceae, Rhodobacteraceae, Nocardioidaceae, Methylobacteriaceae, which appeared to be ethno-specific. Further, we compared microbiome profiles in malignant tissues of three different histological grades. The relative abundance of family Bacteroidaceae decreased and that of genus Agrococcus increased with the development of malignancy. KEGG pathways inferred by PICRUSt showed that biotin and glycerophospholipid metabolism had significant differences in all three grades. Glycerophospholipid and ribosome biogenesis increased in grade III tissue as compared to grades I and II. Flavonoid biosynthesis significantly decreased in grade III tissue. The specific correlation of these potential microbial biomarkers and indicated pathways with advanced disease could have broad implications in the diagnosis and staging of breast cancer. Further large-cohort investigation of the breast cancer microbiome and its potential mechanism in breast cancer development are essential.

24 December 2018 in Endocrine
Verified
Journal Article
Closed access
PDF file
JZJiaming Zhang
Jiaming Zhang
FZFanghua Zhang
Fanghua Zhang
CZChangying Zhao
Changying Zhao
QXQian Xu
Qian Xu
CLCheng Liang
Cheng Liang
LZLei Zhang
Lei Zhang

1 February 2019 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
NLNing Li
Ning Li
JYJunjie Yang
Junjie Yang
JZJiaming Zhang
Jiaming Zhang
CLCheng Liang
Cheng Liang
YWYing Wang
Ying Wang
GZGuoping Zhao
Guoping Zhao
Variation of maternal gut microbiota may increase the risk of autism spectrum disorders (ASDs) in offspring. Animal studies have indicated that maternal gut microbiota is related to neurodevelopmental abnormalities in mouse offspring, while it is unclear whether there is a correlation between gut microbiota of ASD children and their mothers. We examined the relationships between gut microbiome profiles of ASD children and those of their mothers, and evaluated the clinical discriminatory power of discovered bacterial biomarkers. Gut microbiome was profiled and evaluated by 16S ribosomal RNA gene sequencing in stool samples of 59 mother–child pairs of ASD children and 30 matched mother–child pairs of healthy children. Significant differences were observed in the gut microbiome composition between ASD and healthy children in our Chinese cohort. Several unique bacterial biomarkers, such as Alcaligenaceae and Acinetobacter, were identified. Mothers of ASD children had more Proteobacteria, Alphaproteobacteria, Moraxellaceae, and Acinetobacter than mothers of healthy children. There was a clear correlation between gut microbiome profiles of children and their mothers; however, children with ASD still had unique bacterial biomarkers, such as Alcaligenaceae, Enterobacteriaceae, and Clostridium. Candidate biomarkers discovered in this study had remarkable discriminatory power. The identified patterns of mother–child gut microbiome profiles may be important for assessing risks during the early stage and planning of personalized treatment and prevention of ASD via microbiota modulation.

24 September 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YZYan Zhao
Yan Zhao
BCBin Chen
Bin Chen
SLShufeng Li
Shufeng Li
LYLanxiu Yang
Lanxiu Yang
DZDequan Zhu
Dequan Zhu
LZLei Zhang
Lei Zhang
Human intestinal microbes can mediate development of arthritis – Studies indicate that certain bacterial nucleic acids may exist in synovial fluid (SF) and could be involved in arthritis, although the underlying mechanism remains unclear. To characterize potential SF bacterial nucleic acids, we used 16S rRNA gene amplicon sequencing to assess bacterial nucleic acid communities in 15 synovial tissue (ST) and 110 SF samples from 125 patients with rheumatoid arthritis (RA) and 16 ST and 42 SF samples from 58 patients with osteoarthritis (OA). Our results showed an abundant diversity of bacterial nucleic acids in these clinical samples, including presence ofPorphyromonasandBacteroidesin all 183 samples.Agrobacterium,Comamonas,Kocuria,Meiothermus, andRhodoplaneswere more abundant in synovial tissues of rheumatoid arthritis (STRA).Atopobium,Phascolarctobacterium,Rhodotorula mucilaginosa,Bacteroides uniformis,Rothia,Megasphaera,Turicibacter,Leptotrichia,Haemophilus parainfluenzae,Bacteroides fragilis,Porphyromonas, andStreptococcuswere more abundant in synovial tissues of osteoarthritis (STOA).Veillonella dispar,Haemophilus parainfluenzae,Prevotella copriandTreponema amylovorumwere more abundant in synovial fluid of rheumatoid arthritis (SFRA), whileBacteroides caccaewas more abundant in the synovial fluid of osteoarthritis (SFOA). Overall, this study confirms existence of bacterial nucleic acids in SF and ST samples of RA and OA lesions and reveals potential correlations with degree of disease.